Detailed Information

Cited 1,909 time in webofscience Cited 2,175 time in scopus
Metadata Downloads

Alogliptin after acute coronary syndrome in patients with type 2 diabetes

Authors
White W.B.Cannon C.P.Heller S.R.Nissen S.E.Bergenstal R.M.Bakris G.L.Perez A.T.Fleck P.R.Mehta C.R.Kupfer S.Wilson C.Cushman W.C.Zannad F.Aiub J.Albisu J.Alvarez C.Astesiano A.Barcudi R.Bendersky M.Bono J.Bustos B.Cartasegna L.Caruso O.Casabe H.Castro R.Colombo H.Cuneo C.Cura F.De Loredo L.Dran R.Fernandez H.Garcia Pinna J.Hrabar A.Klyver de Saleme M.Luquez H.Mackinnon I.Maffei L.Majul C.Mallagray M.Marino J.Martinez D.Martingano R.Nul D.Parody M.L.Petrucci J.Pieroni M.Piskorz D.Prado A.Ramos H.Resk J.Rodriguez M.Rojas C.Sarjanovich R.Sarries A.Sessa H.Silveiro S.Sosa Liprandi M.I.Tartaglione J.Tonin H.Vallejos J.Vigo S.Visco V.Vita N.Vogel D.Vogelmann O.Zaidman C.Zangroniz P.Colquhoun D.Coverdale S.Flecknoe-Brown S.Hii C.S.Roberts-Thomson P.Drexel H.Luger A.Pieber T.Cools F.Ruige J.Schoors D.Vercammen C.Wollaert B.Alves da Costa F.Amodeo C.Baggenstoss R.Barbosa E.Barroso de Souza W.K.Bassan R.Borges J.L.Botelho R.Braile M.C.Castello H.Chrisman C.dos Santos F.Faria Neto J.Farsky P.Fernandes Da Costa A.Fraige Filho F.Garbelini B.Garcia M.F.Garzon P.Guimaraes A.E.Herdy A.Hernandes M.Hilgemberg S.Hissa M.Jatene J.A.Kormann A.Leaes P.Lima F.Lisboa H.R.Maia L.Maia da Silva F.Maldonado Franco D.Martin J.F.Medeiros A.Michalaros Y.Miguel Leitao A.Montenegro S.Moraes Junior J.Mota Gomes M.Paiva M.S.Precoma D.Rabelo A.Reis G.Reis H.Rossi P.Saporito W.Sarmento Leite R.Silva R.P.Silva Junior D.Sousa L.Sousa A.C.Ueda R.Vilas-Boas F.Wainstein M.Zago A.Angelova M.Apostolova E.Daskalova I.Delchev A.Hristozov K.Ilieva M.Kovacheva S.Lucheva M.Temelkova M.Toneva A.Videva V.Vuchkova E.Bakbak A.Carpentier A.Chan Y.K.Cheema A.Chouinard G.Conway J.Dery J.P.Dowell A.Frechette A.Jakubowski M.Kelly A.Ma P.Maung T.Z.Mehta S.Parker D.Pesant Y.Polasek P.Ransom T.Syan G.Vizel S.Albornoz F.Castro Galvez P.Cobos J.L.Conejeros C.D'Acuña Apablaza M.Fajardo G.Illanes Brochet G.Lazcano M.O.Pincetti C.Potthoff S.Raffo C.Saavedra V.Schnettler M.Sepulveda P.Stockins B.Vejar M.Accini J.L.Cotes Aroca C.H.Fernandez Ruiz R.L.Orozco Linares L.A.Vesga Angarita B.E.Aganovic I.Bagatin J.Canecki-Varzic S.Erzen D.J.Knezevic A.Maric A.Milicevic G.Popovic Z.Rubes J.Weiss S.S.Dresslerova I.Havelkova J.Kucera D.Machacek J.Pumprla J.May O.Perrild H.Aziz M.A.El Badry M.Hasanein M.Airaksinen J.Laine M.Nyman K.Vikman S.Bonnet J.Elbaz M.Henry P.Paillard F.Petit C.Tropeano A.I.Behnke T.Bornstein S.Busch K.Ebelt H.Faghih M.Fischer H.Heuer H.Paschke R.Porner T.C.Tangerding G.Vöhringer H.F.Adamson K.Beatt K.Bellary S.Chapman J.Cooke A.Fisher M.Gnudi L.Jones H.Kumar S.Nagi D.Oldroyd K.Richardson T.Robertson D.Robinson A.Saravanan P.Viljoen A.Wilding J.Wilkinson P.Wong Y.K.Zoupas C.Arango J.Castellanos J.Ceren Flores C.Corona V.Granados-Fuentes A.Haase F.Montenegro P.Prado J.H.Villalobos R.Chow F.Li S.K.Li J.Yan P.Y.Yeung V.Abel T.Benedek A.Dezso E.Dudas M.Édes I.Fulop G.Kovács A.Lupkovics G.Merkely B.Nagy A.Oroszlan T.Palinkas A.Papp A.Patkay J.Simon E.Sitkei E.Tabak A.Tomcsányi J.Abdullakutty J.Abhyankar A.Akalkotkar U.Alexander T.Arneja J.Aslam N.Babu P.R.Babu B.R.Banker D.Bantwal G.Bhimashankar P.R.Calton R.K.Chopda M.Dande A.Dani S.Deshpande N.Dhanwal D.Dharmadhikari A.Gadkari M.Garg N.Ghaisas N.Goyal N.K.Gupta J.B.Jawahirani A.Joseph S.Kumar R.Kumble M.Mathavan A.Mathur A.Mohanan P.P.Nair A.Nair T.Namjoshi D.Pinto R.Prakash G.Purushotham R.Raju S.Ramachandran P.Ramesh S.S.Rao B.Ravikishore A.Reddy G.R.Roy S.Sadhu N.Sastry B.K.Singh P.Srinivas A.Thacker H.Thanvi S.Thomas J.Adawi F.Bashkin A.Cohen J.Harman-Boehm I.Hasin Y.Hayek T.Iakobishvili Z.Katz A.Kracoff O.Minuchin O.Moriel M.Mosseri M.Omary M.Wainstein J.Weiss A.Zeltser D.Calabro P.Derosa G.Genovese S.Novo S.Olivieri C.Piatti P.Violini R.Volpe M.Ajioka M.Amano T.Arasaki O.Daida H.Fujimoto K.Fujinaga H.Higashiue S.Hirohata A.Hosokawa S.Ikefuji H.Inagaki M.Iseki H.Iwabuchi M.Iwasaki T.Kakishita M.Katsuda Y.Kawada K.Kawajiri K.Kawamitsu K.Kobayashi K.Komada F.Komura Y.Machida M.Maemura K.Matsubara T.Matsubayashi S.Matsumoto T.Matsumoto N.Mima T.Miyamoto N.Momiyama Y.Morimoto T.Murakami M.Nakashima E.Niijima Y.Noda T.Node K.Nozaki A.Nunohiro T.Ogawa T.Ono Y.Saeki T.Sakota S.Sakuragi S.Sasaki T.Sato Y.Sueyoshi A.Suzuki M.Takagi G.Tanabe J.Tanaka S.Tei I.Yamamoto M.Yanagihara K.Hong T.J.Jeon H.K.Kang D.H.Kim C.H.Kim D.S.Kim H.S.Kim J.H.Kim S.K.Kim W.S.Kim Y.K.Lee S.R.Lee K.W.Park H.S.Pyun W.B.Rha S.W.Yoon J.Yoon K.H.Bennakhi A.Geldnere K.Sokolova J.Teterovska D.Dautaraite V.Kakariekiene V.Kavaliauskiene R.Kucinskiene A.Lasiene J.Mickuviene N.Palinauskas A.Urboniene A.Zilaitiene B.Abdul Manap H.Abidin I.Z.Isa S.H.Khir A.M.Ng K.H.Tan F.Yusof Z.Yusoff K.Zambahari R.Aguila-Marin J.Aguilera Real M.Alvarado-Ruiz R.Alvarez Lopez H.Arenas Leon J.Bayram Llamas E.A.Calvo Vargas C.Carrillo Calvillo J.De los Rios Ibarra M.Dominguez-Reyes C.A.Duarte M.Elizondo E.Fajardo Campos P.Fanghanel-Salmon G.Figueroa Sauceda S.Gallegos Martinez J.Garcia-Cantu E.Garza Ruiz J.A.Gonzalez Gonzalez J.G.Guerrero Garza M.Hernandez Herrera C.Hernandez Munuzuri J.Hernandez-Garcia H.Jimenez Ramos S.Laviada Molina H.Lopez Villezca D.Montano-Gonzalez E.Nevarez Ruiz L.Ramos Lopez G.Reyes Araiza R.Salazar-Gaytan A.Salcido Vazquez E.Sanchez Mijangos H.Solis Morales L.Benatar J.Dixon P.Nirmalaraj K.Rosen I.Scott R.Young S.Araoz Tarco O.Barreda Cáceres L.Benites Lopez C.Camacho Cosavalente L.Chavez Huapalla E.Chois Malaga A.Copaja Flores A.Farfan Aspilcueta J.Gallardo Rojas W.Gallegos Cazorla A.Galvez Caballero D.Garcia Matheus J.Garrido Carrasco E.Gomez Sanchez J.Hernandez Zuniga J.Lu Galarreta L.Luna A.Manrique Hurtado H.Orihuela Pastor B.Pando Alvarez R.M.Sanchez Povis J.Torres Eguiluz P.Valdivia Portugal A.Vargas Gonzales R.Zapata Rincon L.Aquitania G.Fortinez J.T.Go A.Gomez M.H.Habaluyas R.Jasul G.Magno M.Manalo C.J.Mirasol R.Morales-Palomares E.Salvador D.R.Sy R.A.Tirador L.Yao C.Arciszewska M.Bartkowiak R.Czajkowska-Kaczmarek E.Gil R.Gniot J.Janik K.Janion M.Jaworska K.Jozwa R.Kawecka-Jaszcz K.Kawka-Urbanek T.Kondys M.Korecki J.Korzeniak R.Kowalisko A.Krzeminska-Pakula M.Kwiecien J.Nessler J.Odrowaz-Pieniazek P.Piepiorka M.Rajzer M.Skokowska E.Spyra J.Sroka M.Stasinska T.Szymczyk I.Trznadel-Morawska I.Wysokinski A.Mateus P.Matos P.Mimoso J.Monteiro P.Caballero B.Garcia-Rinaldi R.Gonzalez E.Ortiz-Carrasquillo R.Roman A.Sierra Y.Unger N.Vazquez-Tanus J.Alexandru T.Busegeanu M.Cozman D.C.Fica S.Minescu B.Morosanu M.Negrisanu G.D.Pintilei E.Pop L.Szilagyi I.Teodorescu I.Tomescu M.Barbarash O.Chumakova G.Churina S.Dogadin S.Dvoryashina I.Esip V.Glezer M.Gordeev I.Gordienko A.Gratsiansky N.Grineva E.Khasanov N.Kostenko V.Meleshkevich T.Mikhin V.Morugova T.Motylev I.Nikolaev K.Y.Ponomareva A.Repin M.Reshetko O.Shustov S.Shutemova E.Shvarts Y.Simanenkov V.Sobolev K.Sukmanova I.Timofeev A.Tsyba L.Varvarina G.Vertkin A.Vishnevsky A.Volkov D.Vorobiev S.Vorokhobina N.Yakhontov D.Zonova E.Zrazhevskiy K.Damjanovic S.Djordjevic D.Pavlovic M.Perunicic J.Ristic A.Stojkovic S.Tasic N.Bolvanska N.Buganova I.Dulkova K.Dzupina A.Fulop P.Gergel V.Kokles M.Micko K.Svoren P.Urban M.Vadinova S.Vargova A.Burgess L.Coetzee K.Du Toit J.Gani M.Joshi P.Naiker P.Nortje H.Sarvan M.Seeber M.Siebert M.van Zyl L.Wellmann H.Calvo C.De la Hera J.De Teresa L.Melero-Pita A.Mesa J.Parra Barona J.Serrano P.Soto A.Tofe S.Hornestam B.Kempe A.Rosenqvist U.Rydberg E.Tengmark B.O.Torstensson I.Chang C.T.Hsia T.L.Hsieh I.C.Lai W.T.Wu C.J.Hutayanon P.Kosachunhanun N.Marapracertsak M.Piamsomboon C.Seekaew S.Srimahachota S.Sukhum P.Suraamornkul S.Tantiwong P.Wongvipaporn C.Amosova K.Barna O.Bazylevych A.Berenfus V.Dyadyk A.Fushtey I.Gyrina O.Iabluchanskyi M.Karpenko O.Kaydashev I.Korzh O.Kulynych R.Legkonogov O.Mankovsky B.Mostovoy Y.Parkhomenko O.Popik G.Rudenko L.Rudyk I.Shevchuk S.Sirenko Y.Suprun Y.Tryshchuk N.Tseluyko V.Vakaliuk I.Al Mahmeed W.Acheatel R.Ahmad A.Akbar S.Akhter F.Albirini A.Alexander A.Al-Joundi B.Al-Joundi T.Allen G.Aloi J.Alvarado O.Alzohaili O.Anderson C.Arastu A.Arena C.Argoud G.Ariani M.Arora C.Awasty V.Barker B.Barnum O.Bartkowiak A.J.Barzilay J.Behrens P.Belledonne M.Bergman B.Bilnoski W.Bisognano J.Bissette S.Blumberg E.Bonabi N.Bradley A.Breton C.Britos M.Broadstone V.Budoff M.Burge M.Butman S.Carroll M.Challappa K.Chepuri V.Cherlin R.Cheung D.Coats P.Collins J.Cruz H.Daboul N.Damberg G.David W.Dean J.Dedeke E.Deeb W.DeHaven J.Dobs A.Donelan T.Dy J.Dykstra G.Eisen H.Farris N.Fattal P.Fishman N.Foster M.Fredrickson S.Gabra N.Gabriel J.Gatien L.Giddings S.Ginsberg B.Gips S.Glandt M.Goldfein A.Gordon M.Gould R.Graf R.Graham B.Graves M.Grena P.Hahn R.Hamilton D.Hamroff G.Hanke F.Haque I.Harper J.Harris A.Harris S.Henson B.Hermanns D.Herndon W.Hershberger V.Hyman D.Isserman S.Iteld B.Jacob M.Jaffrani N.Jamal A.Johnson D.Johnson G.Kaluski E.Keller R.Kereiakes D.Khan M.Khan S.Klein M.Knutson T.Korban E.Kozinn M.Kraft P.Kroeze J.Kukuy E.Lader E.Laliotis A.Lambert C.Landau C.Latif K.Lee K.Lester F.Levenson D.Levinson D.Lewis D.Litt M.Littlefield R.Lo E.Lovell C.Mahal S.Makam S.Mandviwala M.Marar I.Masri B.Mattson S.Mays M.McGrew F.Meengs M.Mikell F.Miller M.Miranda F.Moll D.Multani P.Munuswamy K.Nallasivan M.Nayles L.Ong S.Pacheco T.Paez H.Patel S.Phillips R.Pierpont B.Prasad J.Quinlan E.Quion J.Qureshi M.Rahman A.Raikhel M.Ramanathan K.Randhawa P.Ravi R.Reddy R.Rendell M.Rickner K.Rictor K.Rivas J.Rosenblit P.Rosenstock J.Ross S.Salacata A.Saririan M.Schima S.Schlau A.Schmedtje J.Scott C.Scott D.Serru-Paez A.Shah R.Shah A.Shaoulian E.Shomali M.Shubrook J.Silver K.Singh S.Speer J.Stevens J.Stringam S.Taussig A.Taylor A.Tee H.Teixeira G.Tilley A.Toggart E.Twahirwa M.Unks D.Vakili B.Vora K.Wang X.Warner A.Wefald F.Weinberg B.Weinstein D.White L.Wu P.Yasuda T.Yazdani S.Yetman C.Zarich S.Zebrack J.Fonseca V.A.McCullough P.A.Desouza C.Goff D.C.Harrell F.E.Menon V.Sila C.Kalahasti V.Ahmed S.Al Solaiman F.Bennett M.Cavender M.Heil B.Katzan I.Monteleone P.O'Brien B.Oommen S.Senn T.Sharma J.Stegman B.Uchino K.Zishiri E.Pasca N.Brown K.Scebbi T.Atanasovski I.McCue M.Streit J.Oh R.Bueno O.Lee D.Camisasca R.Miyata Y.Rubin A.Williamson N.Vara S.Keeter K.Ross B.de los Reyes A.Donnelly J.Koshy-Hunt S.Beers B.Black S.Buckley M.Ephrem M.Riley B.West N.Harre M.Hsieh R.Oshinyemi K.Oka Y.Matsui N.Hoang M.Doyle C.Koziol M.Lam H.Edmonds A.Azooz W.Cao C.Kim D.Boeshaar A.Dewindt A.Nicholson K.Smith N.Hisada M.Harding S.Yoshioka N.Gujral-Sandhu K.Gans J.Gresk C.Kujawski M.R.Villinski A.Cosner S.Johannsen C.Barchha N.EXAMINE Investigators
Issue Date
Oct-2013
Publisher
Massachussetts Medical Society
Citation
New England Journal of Medicine, v.369, no.14, pp 1327 - 1335
Pages
9
Indexed
SCI
SCIE
SCOPUS
Journal Title
New England Journal of Medicine
Volume
369
Number
14
Start Page
1327
End Page
1335
URI
https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/30648
DOI
10.1056/NEJMoa1305889
ISSN
0028-4793
1533-4406
Abstract
BACKGROUND: To assess potentially elevated cardiovascular risk related to new antihyperglycemic drugs in patients with type 2 diabetes, regulatory agencies require a comprehensive evaluation of the cardiovascular safety profile of new antidiabetic therapies. We assessed cardiovascular outcomes with alogliptin, a new inhibitor of dipeptidyl peptidase 4 (DPP-4), as compared with placebo in patients with type 2 diabetes who had had a recent acute coronary syndrome. METHODS: We randomly assigned patients with type 2 diabetes and either an acute myocardial infarction or unstable angina requiring hospitalization within the previous 15 to 90 days to receive alogliptin or placebo in addition to existing antihyperglycemic and cardiovascular drug therapy. The study design was a double-blind, noninferiority trial with a prespecified noninferiority margin of 1.3 for the hazard ratio for the primary end point of a composite of death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke. RESULTS: A total of 5380 patients underwent randomization and were followed for up to 40 months (median, 18 months). A primary end-point event occurred in 305 patients assigned to alogliptin (11.3%) and in 316 patients assigned to placebo (11.8%) (hazard ratio, 0.96; upper boundary of the one-sided repeated confidence interval, 1.16; P<0.001 for noninferiority). Glycated hemoglobin levels were significantly lower with alogliptin than with placebo (mean difference, -0.36 percentage points; P<0.001). Incidences of hypoglycemia, cancer, pancreatitis, and initiation of dialysis were similar with alogliptin and placebo. CONCLUSIONS: Among patients with type 2 diabetes who had had a recent acute coronary syndrome, the rates of major adverse cardiovascular events were not increased with the DPP-4 inhibitor alogliptin as compared with placebo. Copyright © 2013 Massachusetts Medical Society.
Files in This Item
There are no files associated with this item.
Appears in
Collections
2. Clinical Science > Department of Cardiology > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Rha, Seung Woon photo

Rha, Seung Woon
Guro Hospital (Department of Cardiology, Guro Hospital)
Read more

Altmetrics

Total Views & Downloads

BROWSE